Cargando…
Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment
Stimulus-responsive drug delivery systems generally aim to release the active pharmaceutical ingredient (API) in response to specific conditions and have recently been explored for disease treatments. These approaches can also be extended to molecular imaging to report on disease diagnosis and manag...
Autores principales: | Liu, Gengqi, Lovell, Jonathan F., Zhang, Lei, Zhang, Yumiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504550/ https://www.ncbi.nlm.nih.gov/pubmed/32887466 http://dx.doi.org/10.3390/ijms21176380 |
Ejemplares similares
-
State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer
por: Kong, Chenfan, et al.
Publicado: (2022) -
Porphyrins as Theranostic Agents from Prehistoric to Modern Times
por: Zhang, Yumiao, et al.
Publicado: (2012) -
Polymeric nanomedicines for the treatment of hepatic diseases
por: Luo, Feixiang, et al.
Publicado: (2022) -
Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines
por: Šubr, Vladimír, et al.
Publicado: (2022) -
Ferritin-based nanomedicine for disease treatment
por: Zhu, Yuanjun, et al.
Publicado: (2023)